Exact Sciences (EXAS) Net Cash Flow (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Net Cash Flow data on file, last reported at $166.9 million in Q4 2025.

• Net Cash Flow for Q4 2025 came in at $166.9 million, up 963.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $348.5 million (up 136554.51% YoY), and the FY2025 annual result was $348.5 million, up 136554.51% from the prior year.
• Net Cash Flow grew to $166.9 million in Q4 2025 per EXAS's latest filing, from $131.9 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $309.4 million in Q2 2025 and troughed at -$740.1 million in Q2 2021.
• A 5-year average of -$26.7 million and a median of $19.9 million in 2022 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2021 and 2025: Net Cash Flow slumped 25851.15% in 2021, then soared 963.95% in 2025.
• A 5-year view of Net Cash Flow shows it stood at $41.7 million in 2021, then tumbled by 90.45% to $4.0 million in 2022, then jumped by 222.0% to $12.8 million in 2023, then increased by 22.4% to $15.7 million in 2024, then soared by 963.95% to $166.9 million in 2025.
• Business Quant data shows EXAS's Net Cash Flow at $166.9 million in Q4 2025, $131.9 million in Q3 2025, and $309.4 million in Q2 2025.